Credit Agricole - Egypt Bank (S.A.E.) (EGX:CIEB)

Theseus Pharmaceuticals Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,898	53,309	47,740	27,578	1,778	8,153
Investment Securities	60,642	13,481	10,711	8,123	22,437	12,531
Trading Asset Securities	486.22	441.46	404.88	66.63	31.53	212.62
Total Investments	61,129	13,922	11,116	8,189	22,469	12,744
Gross Loans	59,445	55,490	42,899	35,301	31,182	27,096
Allowance for Loan Losses	-2,327	-2,207	-1,716	-1,484	-1,512	-1,350
Other Adjustments to Gross Loans	-1.99	-4.66	-14.38	-6.14	-93.88	-70.26
Net Loans	57,116	53,278	41,169	33,810	29,576	25,676
Property, Plant & Equipment	883.26	726.81	594.51	586.01	575.95	646.87
Other Intangible Assets	351.99	256.54	176.23	115.21	137.55	126.68
Accrued Interest Receivable	2,200	1,635	975	743.87	538.4	443.98
Other Receivables	4,180	-	-	-	1,269	-
Restricted Cash	5,018	2,179	2,974	3,425	3,370	3,415
Other Current Assets	358.63	476.43	372.63	302.15	306.59	337.66
Long-Term Deferred Tax Assets	-	-	61.19	9.34	-	-
Other Real Estate Owned & Foreclosed	48.6	48.6	115.17	117.97	58.51	58.51
Other Long-Term Assets	916.47	1,066	884.14	488.54	309.32	290.58
Total Assets	135,100	126,898	106,178	75,366	60,388	51,892
Accrued Expenses	1,095	852.51	673.96	561.5	470.83	492.84
Interest Bearing Deposits	78,652	74,233	65,996	44,734	38,658	33,003
Non-Interest Bearing Deposits	26,011	21,734	18,378	16,219	9,557	8,292
Total Deposits	104,663	95,967	84,374	60,954	48,216	41,295
Short-Term Borrowings	263.56	338.24	12.54	45.18	20.17	75.44
Current Portion of Long-Term Debt	-	104.18	55.92	104.32	78.68	70.18
Current Income Taxes Payable	1,139	1,815	1,502	644.32	288.72	223.98
Accrued Interest Payable	605.57	572.87	582.48	221.04	250.37	203.9
Long-Term Debt	1,671	1,665	1,021	892.55	599.43	571.55
Long-Term Unearned Revenue	97.26	93.78	55.19	53.75	36.62	34.44
Pension & Post-Retirement Benefits	223.41	223.41	140.26	190.98	163.9	165
Long-Term Deferred Tax Liabilities	38.39	134.76	-	-	0.1	0.14
Other Long-Term Liabilities	5,210	3,686	3,256	1,785	1,603	1,524
Total Liabilities	115,006	105,452	91,673	65,452	51,727	44,657
Common Stock	5,000	5,000	5,000	5,000	5,000	1,244
Retained Earnings	14,318	15,671	9,621	4,718	3,517	5,687
Comprehensive Income & Other	774.89	775.58	-115.86	196.43	144.26	303.69
Total Common Equity	20,093	21,446	14,505	9,914	8,661	7,235
Minority Interest	0.02	0.02	0.02	0.02	0.02	0.02
Shareholders' Equity	20,093	21,446	14,505	9,914	8,661	7,235
Total Liabilities & Equity	135,100	126,898	106,178	75,366	60,388	51,892
Total Debt	1,935	2,107	1,090	1,042	698.28	717.17
Net Cash (Debt)	38,424	55,723	49,454	28,519	10,091	8,658
Net Cash Growth	-2.36%	12.68%	73.41%	182.63%	16.55%	23.92%
Net Cash Per Share	30.74	44.58	39.56	22.81	8.07	6.93
Filing Date Shares Outstanding	1,250	1,250	1,250	1,250	1,250	1,250
Total Common Shares Outstanding	1,250	1,250	1,250	1,250	1,250	1,250
Book Value Per Share	16.07	17.16	11.60	7.93	6.93	5.79
Tangible Book Value	19,741	21,190	14,329	9,799	8,523	7,108
Tangible Book Value Per Share	15.79	16.95	11.46	7.84	6.82	5.69

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.